American Well Co. (NYSE:AMWL) Insider Phyllis Gotlib Sells 4,781 Shares

American Well Co. (NYSE:AMWL) insider Phyllis Gotlib sold 4,781 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $8.80, for a total value of $42,072.80. Following the transaction, the insider now directly owns 147,998 shares in the company, valued at approximately $1,302,382.40. This represents a 3.13 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Phyllis Gotlib also recently made the following trade(s):

• On Monday, February 3rd, Phyllis Gotlib sold 299 shares of American Well stock. The shares were sold at an average price of $10.51, for a total value of $3,142.49.

American Well Price Performance

Shares of NYSE:AMWL traded up $0.03 during trading hours on Wednesday, hitting $8.73. The company’s stock had a trading volume of 56,633 shares, compared to its average volume of 76,956. The firm’s fifty day moving average price is $9.84 and its 200 day moving average price is $9.34. American Well Co. has a 52 week low of $5.00 and a 52 week high of $21.60. The company has a market capitalization of $136.23 million, a price-to-earnings ratio of -0.62 and a beta of 1.18.

American Well (NYSE:AMWL) last issued its quarterly earnings data on Wednesday, February 12th. The company reported ($2.77) EPS for the quarter, topping analysts’ consensus estimates of ($3.04) by $0.27. American Well had a negative net margin of 81.83% and a negative return on equity of 56.73%. On average, equities research analysts predict that American Well Co. will post -9.34 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on AMWL shares. Truist Financial lifted their target price on American Well from $10.00 to $12.00 and gave the stock a “hold” rating in a research report on Friday, February 14th. Morgan Stanley decreased their price objective on shares of American Well from $20.00 to $10.50 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Needham & Company LLC restated a “hold” rating on shares of American Well in a research note on Thursday, February 13th. Wells Fargo & Company raised shares of American Well from an “equal weight” rating to an “overweight” rating and set a $15.00 target price on the stock in a research report on Monday, January 13th. Finally, Stifel Nicolaus boosted their price target on American Well from $9.00 to $10.00 and gave the company a “hold” rating in a report on Thursday, February 13th. Five equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $11.90.

Hedge Funds Weigh In On American Well

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC increased its position in shares of American Well by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 147,925 shares of the company’s stock valued at $1,073,000 after acquiring an additional 922 shares during the period. Northern Trust Corp increased its holdings in shares of American Well by 7.4% in the fourth quarter. Northern Trust Corp now owns 29,021 shares of the company’s stock valued at $210,000 after purchasing an additional 1,992 shares during the period. Two Sigma Investments LP raised its stake in shares of American Well by 12.3% in the fourth quarter. Two Sigma Investments LP now owns 19,216 shares of the company’s stock worth $139,000 after purchasing an additional 2,102 shares during the last quarter. Jane Street Group LLC lifted its holdings in shares of American Well by 21.9% during the fourth quarter. Jane Street Group LLC now owns 19,260 shares of the company’s stock worth $140,000 after purchasing an additional 3,462 shares during the period. Finally, Compagnie Lombard Odier SCmA acquired a new stake in shares of American Well during the fourth quarter worth about $45,000. 56.05% of the stock is owned by hedge funds and other institutional investors.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.